Of note, Browne et al. recently reported an association of RUNX1 with breast cancer progression in MMTV-PyMT transgenic mice [24], and some studies have shown that ablation of RUNX1 in other epithelial cancers dramatically reduces tumor burden [94]. Here, RUNX1 is linked to breast carcinoma.